Cargando…
Integrated Multi-Omics Signature Predicts Survival in Head and Neck Cancer
Head and Neck Cancer (HNC) is characterized by phenotypic, biological, and clinical heterogeneity. Despite treatment modalities, approximately half of all patients will die of the disease. Several molecular biomarkers have been investigated, but until now, without clinical translation. Here, we iden...
Autores principales: | Ribeiro, Ilda Patrícia, Esteves, Luísa, Caramelo, Francisco, Carreira, Isabel Marques, Melo, Joana Barbosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406438/ https://www.ncbi.nlm.nih.gov/pubmed/36010616 http://dx.doi.org/10.3390/cells11162536 |
Ejemplares similares
-
Genomic predictive model for recurrence and metastasis development in head and neck squamous cell carcinoma patients
por: Ribeiro, Ilda Patrícia, et al.
Publicado: (2017) -
Genomic and epigenetic signatures associated with survival rate in oral squamous cell carcinoma patients
por: Ribeiro, Ilda Patrícia, et al.
Publicado: (2018) -
Probability distribution of copy number alterations along the genome: an algorithm to distinguish different tumour profiles
por: Esteves, Luísa, et al.
Publicado: (2020) -
Head and neck cancer: searching for genomic and epigenetic biomarkers in body fluids – the state of art
por: Ribeiro, Ilda Patrícia, et al.
Publicado: (2019) -
Early detection and personalized treatment in oral cancer: the impact of omics approaches
por: Ribeiro, Ilda Patrícia, et al.
Publicado: (2016)